These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7131162)

  • 1. Applied pharmacokinetics in acute exacerbations of Pseudomonas aeruginosa pneumonia in cystic fibrosis.
    Fraser GL; Grimes GR; Valenti AJ
    J Pediatr; 1982 Nov; 101(5):792-4. PubMed ID: 7131162
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal.
    Nelson JD
    J Pediatr; 1985 Jun; 106(6):1030-4. PubMed ID: 3889252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial chemotherapy in patients with cystic fibrosis.
    Guggenbichler JP; Schneeberger J
    Infection; 1987; 15(5):397-402. PubMed ID: 3692614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tobramycin in cystic fibrosis.
    Kelly HB; Menendez R; Fan L; Murphy S
    J Pediatr; 1982 Feb; 100(2):318-21. PubMed ID: 7057342
    [No Abstract]   [Full Text] [Related]  

  • 5. [Macrolides, Pseudomonas aeruginosa and cystic fibrosis].
    Guillot M; Amiour M; El Hachem C; Harchaoui S; Ribault V; Paris C
    Arch Pediatr; 2006 Oct; 13 Suppl 1():S48-50. PubMed ID: 17370396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa.
    Scully BE; Neu HC; Parry MF; Mandell W
    Lancet; 1986 Apr; 1(8485):819-22. PubMed ID: 2870313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.
    Young DC; Zobell JT; Stockmann C; Waters CD; Ampofo K; Sherwin CM; Spigarelli MG
    Pediatr Pulmonol; 2013 Nov; 48(11):1047-61. PubMed ID: 24000183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis and chronic pulmonary infection with Pseudomonas aeruginosa: Is gross domestic product (GDP) involved?
    Moore JE; Millar BC
    J Infect; 2023 Oct; 87(4):e75-e77. PubMed ID: 37536449
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Kerrebijn KF; Mouton J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):28-33. PubMed ID: 2130712
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pseudomonas infections in lungs of children born with cystic fibrosis. Effects and adverse effects during antibiotic therapy with tobramycin and carbenicillin].
    Friis B; Thomsen J
    Ugeskr Laeger; 1979 Jul; 141(29):1968-72. PubMed ID: 545764
    [No Abstract]   [Full Text] [Related]  

  • 11. Exacerbations in cystic fibrosis: 3--Management.
    Smyth A; Elborn JS
    Thorax; 2008 Feb; 63(2):180-4. PubMed ID: 18234661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of aminoglycosides pharmacokinesis in C.F. patients in relation with certain clinical parameters.
    Douchain F; Lebas L; Houdas S; Chivet C; Bakhache P; Pautard JC
    Acta Univ Carol Med (Praha); 1990; 36(1-4):37-9. PubMed ID: 2130714
    [No Abstract]   [Full Text] [Related]  

  • 13. Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis.
    Faruqi S; McCreanor J; Moon T; Meigh R; Morice AH
    Int J Antimicrob Agents; 2008 Nov; 32(5):461-3. PubMed ID: 18703318
    [No Abstract]   [Full Text] [Related]  

  • 14. A systematic Cochrane Review of antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.
    Hurley MN; Smith S; Forrester DL; Smyth AR
    Paediatr Respir Rev; 2020 Nov; 36():109-111. PubMed ID: 33129669
    [No Abstract]   [Full Text] [Related]  

  • 15. Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis.
    Parry MF; Neu HC
    J Infect Dis; 1976 Aug; 134 Suppl():S194-7. PubMed ID: 823276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis].
    Prévotat A; Leroy S; Perez T; Wallet F; Wallaert B
    Rev Mal Respir; 2010 May; 27(5):449-56. PubMed ID: 20569877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulised antipseudomonal therapy in cystic fibrosis.
    Touw DJ; Bakker W
    Thorax; 1996 Dec; 51(12):1283. PubMed ID: 8994535
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
    da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
    Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.